- 专利标题： Fused pyrimidine compound or salt thereof
-
申请号： US16855226申请日： 2020-04-22
-
公开(公告)号： US11014930B2公开(公告)日： 2021-05-25
- 发明人: Isao Miyazaki , Tadashi Shimamura , Masanori Kato , Hidenori Fujita
- 申请人： TAIHO PHARMACEUTICAL CO., LTD.
- 申请人地址： JP Tokyo
- 专利权人： TAIHO PHARMACEUTICAL CO., LTD.
- 当前专利权人： TAIHO PHARMACEUTICAL CO., LTD.
- 当前专利权人地址： JP Tokyo
- 代理机构： Rothwell, Figg, Ernst & Manbeck, P.C.
- 优先权： JP2015-177073 20150908
- 主分类号： C07D487/04
- IPC分类号： C07D487/04 ; C07D519/00 ; A61P35/04 ; A61K31/519 ; A61K31/5377
摘要：
The present invention provides a novel RET inhibitor comprising, as an active ingredient, a compound or a salt thereof that have not been known for their RET inhibitory activity, and also provides an agent for preventing or treating diseases (e.g., malignant tumors) that can be prevented or treated by RET inhibitory activity. The RET inhibitor comprises, as an active ingredient, a compound represented by Formula (I) below or a salts thereof: wherein A, R1 to R3, X, and n are as defined in the specification.
公开/授权文献
- US10981920B2 Fused pyrimidine compound or salt thereof 公开/授权日：2021-04-20
信息查询
